estriol has been researched along with Graft vs Host Disease in 1 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Michala, L | 1 |
| Vlachopapadopoulou, E | 1 |
| Tsimaris, P | 1 |
| Papaioannou, G | 1 |
| Paisiou, A | 1 |
| Peristeri, I | 1 |
| Michalacos, S | 1 |
| Kitra, V | 1 |
1 other study available for estriol and Graft vs Host Disease
| Article | Year |
|---|---|
Resolution of Hematocolpos in Adolescents Affected with Graft vs Host Disease.
Topics: Adolescent; Bone Marrow Transplantation; Child; Estriol; Female; Graft vs Host Disease; Hematocolpos | 2018 |